Yahoo Finance

Biosynex Completes Acquisition of Chembio Diagnostics, Inc.

STRASBOURG, France, April 27, 2023 (GLOBE NEWSWIRE) -- Biosynex SA (“Biosynex”) (EPA: ALBIO), a French market leader specializing in the design and distribution of rapid tests, today announced it has ...
Yahoo Finance

Biosynex and Chembio Diagnostics Announce Definitive Acquisition Agreement

STRASBOURG, France and HAUPPAUGE, N.Y., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Biosynex SA (“Biosynex”) (EPA: ALBIO), a French market leader specializing in the design and distribution of rapid tests, and ...
Newsday

Chembio merger in doubt as shareholders refuse to sell their stock

Shareholders of Chembio Diagnostics Inc. haven’t yet agreed to a proposed merger with a French firm, despite warnings that the Medford test maker could file for bankruptcy or even close permanently if ...
Nasdaq

Chembio Diagnostics Completes Acquisition of Orangelife

MEDFORD, N.Y., Nov. 25, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced that it has ...
Nasdaq

Chembio Diagnostics Announces Appointment of Larry Steenvoorden as Chief Financial Officer

HAUPPAUGE, N.Y., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced the appointment ...
Business Insider

Chembio Diagnostics Announces Completion of U.S. Clinical Trial Evaluating DPP® HIV-Syphilis SystemU.S. Regulatory Submission for DPP® HIV-Syphilis System Expected in Q1 2018

MEDFORD, N.Y., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced completion of the ...
Benzinga.com

Chembio Diagnostics And 2 Other Stocks Under $1 Insiders Are Aggressively Buying

The Dow Jones closed higher by around 380 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders ...
The Globe and Mail

Chembio Diagnostics Receives $4 Million HIV Test Purchase Order Supported by The Global Fund

HAUPPAUGE, N.Y., July 22, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, announced its receipt today of a ...
CNN

Chembio Diagnostics Announces Closing of Public Offering of Common Stock

HAUPPAUGE, N.Y., May 11, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI) (“Chembio”), a leading point-of-care diagnostic company focused on infectious diseases, announced today the ...
Newsday

Chembio Diagnostics settles with SEC as sale to Biosynex nears

A manufacturer of rapid diagnostic tests in Hauppauge has paid $500,000 to end an investigation by the U.S. Securities and Exchange Commission, according to a securities filing. Chembio Diagnostics ...
Benzinga.com

Why Is Chembio Diagnostics (NASDAQ: CEMI) The Best Stock Of The Day?

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Chembio Diagnostics is a biotech firm based ...
Seeking Alpha

Biosynex Completes Acquisition of Chembio Diagnostics, Inc.

Chembio Diagnostics, Inc. (CEMI) becomes the first North American structure controlled by Biosynex in North America STRASBOURG, France, April 27, 2023 (GLOBE NEWSWIRE) -- Biosynex SA (“Biosynex”) (EPA ...